•  
  •  
  •  
  •  

2025-12-17 02:52:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Tamilnadu Petroproducts Ltd receives TNPCB nod for expanded capacity of Linear Alkyl Benzene plant
  • S&P Upgrades IIFL Finance's Outlook to 'Positive' On Recovering Market Share in Gold Loans, 'B+/B' Ratings Affirmed
  • Trishakti Industries Ltd secures order from Afcons Infrastructure Ltd
  • Persistent and DigitalOcean announce strategic partnership to advance accessible, scalable and secure AI
  • ITCONS E-Solutions Ltd bags new contract

Keywords Selected:  APIManufacturingFacility

Stock Report

  • Successful completion of USFDA inspection at Vizag facility
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
  • Lupin achieves GMP Certification from TGA Australia for Dabhasa API Facility
  • SMS Lifesciences India Ltd receives EIR with VAI status from USFDA for API facility at Kazipally
  • Zydus receives EIR for the API manufacturing facility at Ankleshwar
  • USFDA classifies Emcure Pharmaceuticals Ltd's API facility at Kurkumbh as VAI
  • Laurus Labs Limited receives EIR for API facility Unit-4
  • Apitoria Pharma Pvt Ltd's API manufacturing facility classified as VAI by USFDA
  • Aarti Drugs Ltd receives Form 483 with 7 observations from USFDA after inspection at API facility
  • Fermenta Biotech Ltd's API manufacturing facility receives certificate of EU GMP compliance
  • Laurus Labs concludes successful USFDA audit for API Manufacturing Facility at Hyderabad
  • U.S. FDA completes inspection of Lupin's Dabhasa Facility with No Observations
  • Dr. Reddy's Laboratories Ltd receives EIR from USFDA for API facility at Bollaram
  • Dr. Reddy's Laboratories Limited's API facility at Srikakulam completes USFDA inspection successfully
  • Lupin receives EIR from US FDA for its API Manufacturing Facility in Vizag
  • Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam
  • Dr. Reddy's Laboratories Limited updates on USFDA GMP inspection at Bollaram unit
  • Morepen Laboratories Ltd announces successful completion of USFDA inspection of API facility at Baddi
  • U.S. FDA Completes Inspection of Lupin's Vizag Facility with No Observations
  • SMS Lifesciences India Ltd receives EIR from USFDA for API manufacturing facility

Latest Post

  • Tamilnadu Petroproducts Ltd receives TNPCB nod for expanded capacity of Linear Alkyl Benzene plant
  • S&P Upgrades IIFL Finance's Outlook to 'Positive' On Recovering Market Share in Gold Loans, 'B+/B' Ratings Affirmed
  • Trishakti Industries Ltd secures order from Afcons Infrastructure Ltd
  • Persistent and DigitalOcean announce strategic partnership to advance accessible, scalable and secure AI
  • ITCONS E-Solutions Ltd bags new contract


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024